|
WO2013168176A2
|
|
Process for preparation of fosaprepitant and salt thereof
|
|
WO2013121439A2
|
|
Garenoxacin mesylate, process for preparation thereof, and crystalline form thereof.
|
|
EP2807143A2
|
|
Process for preparation of fingolimod
|
|
WO2013072933A2
|
|
Process for preparation of 2-acetamido-n-benzyl-3-methoxypropionamide
|
|
WO2013072921A2
|
|
Process for preparation of substituted 3'-hydrazino-biphenyl-3-carboxylic acid compounds
|
|
WO2013046225A2
|
|
Process for the preparation of paliperidone palmitate
|
|
WO2013046222A2
|
|
A process for the preparation of amorphous rosuvastatin calcium
|
|
WO2013038424A2
|
|
Process for purifying diacerein
|
|
WO2012153348A2
|
|
Process for preparation of prasugrel and its intermediates
|
|
WO2012156987A2
|
|
Novel process for preparation of eslicarbazepine
|
|
WO2012147098A2
|
|
Novel process for preparation of 3-(cyclopropylmethoxy)-n-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy) benzamide
|
|
WO2012007959A1
|
|
Process for preparing dronedarone
|
|
EP2582690A1
|
|
Process for preparation of 2, 3-diaryl-5-substituted pyridines and their intermediates
|
|
WO2011095984A1
|
|
A process for the preparation of amorphous esomeprazole
|
|
US2011052687A1
|
|
Extended release pharmaceutical composition of paliperidone
|
|
US2011053898A1
|
|
Topical composition comprising vitamin d analogue and corticosteroids
|
|
US2011038928A1
|
|
Orally disintegrating tablets of zolmitriptan
|
|
WO2011004392A1
|
|
Crystalline form of prasugrel hydrobromide, preparation and application thereof
|
|
US2011207779A1
|
|
Process for the preparation of esomeprazole magnesium
|
|
EP2424839A2
|
|
A process for the preparation of lasofoxifene tartrate
|
